Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells
- PMID: 1390844
- DOI: 10.1016/0005-2736(92)90353-n
Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells
Abstract
The influence of dextran sulfate with molecular weights of 500,000 and 8000 on binding and fusion of influenza virus (X31 strain) and of cells expressing influenza hemagglutinin (GP4F) with red blood cells (RBC) was investigated by spectrofluorimetry using virus and RBC labeled with the fluorescent dye octadecyl rhodamine B (R18). There was no significant inhibition of binding of virus and GP4F cells to red blood cells by dextran sulfate, but the polymer strongly inhibited the low pH induced fusion. Virus-RBC fusion was completely blocked by the high molecular weight dextran sulfate at concentrations as low as 0.5 mg/ml. Inhibition of RBC-GP4F cell fusion by dextran sulfate in the same concentration range was not as pronounced but the effect was potentiated by Ca2+. The polymer was only inhibitory when added at early steps of the fusion reaction, but the pH-induced conformational change of the hemagglutinin was not affected by dextran sulfate as measured by its susceptibility to proteolytic digestion. Removal of dextran sulfate after low pH-requiring steps allowed the system to fuse at neutral pH indicating that the inhibitory effect requires the continuous presence of dextran sulfate during the fusion reaction.
Similar articles
-
The influence of dextran sulfate on influenza A virus fusion with erythrocyte membranes.Antiviral Res. 1992 Oct 1;19(4):295-311. doi: 10.1016/0166-3542(92)90011-s. Antiviral Res. 1992. PMID: 1463322
-
Fusion and infection of influenza and Sendai viruses as modulated by dextran sulfate: a comparative study.Biosci Rep. 2001 Jun;21(3):293-304. doi: 10.1023/a:1013282015121. Biosci Rep. 2001. PMID: 11892996
-
A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus.Arch Virol. 1993;130(3-4):317-26. doi: 10.1007/BF01309663. Arch Virol. 1993. PMID: 8517791
-
Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.J Virol. 1991 May;65(5):2402-7. doi: 10.1128/JVI.65.5.2402-2407.1991. J Virol. 1991. PMID: 1850019 Free PMC article.
-
Influenza hemagglutinin: kinetic control of protein function.Structure. 1994 Oct 15;2(10):907-10. doi: 10.1016/s0969-2126(94)00091-3. Structure. 1994. PMID: 7866741 Review.
Cited by
-
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.J Prev Med Hyg. 2014 Dec;55(4):109-29. J Prev Med Hyg. 2014. PMID: 26137785 Free PMC article. Review.
-
Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B.J Virol. 1997 Jan;71(1):191-8. doi: 10.1128/JVI.71.1.191-198.1997. J Virol. 1997. PMID: 8985338 Free PMC article.
-
Emerging antiviral strategies to interfere with influenza virus entry.Med Res Rev. 2014 Mar;34(2):301-39. doi: 10.1002/med.21289. Epub 2013 Jun 25. Med Res Rev. 2014. PMID: 23801557 Free PMC article. Review.
-
Progress of small molecular inhibitors in the development of anti-influenza virus agents.Theranostics. 2017 Feb 8;7(4):826-845. doi: 10.7150/thno.17071. eCollection 2017. Theranostics. 2017. PMID: 28382157 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous